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CurrentConceptsReview
Resuming Elective Orthopaedic Surgery
During the COVID-19 Pandemic
Guidelines Developed by the International Consensus Group (ICM)
J. Parvizi, MD, FRCS, T. Gehrke, MD, C.A. Krueger, MD, E. Chisari, MD, M. Citak, MD, PhD, S. Van Onsem, MD, PhD, and
W.L. Walter, MBBS, PhD, the International Consensus Group (ICM) and Research Committee of the American Association
of Hip and Knee Surgeons (AAHKS)*
 As we resume elective surgical procedures, it is important to understand what practices and protocols should be
altered or implemented in order to minimize the risk of pathogen transfer during the severe acute respiratory
syndrome (SARS)-CoV-2 pandemic.
 Each hospital and health system should consider their unique situation in terms of SARS-CoV-2 prevalence,
staffing capabilities, personal protection equipment supply, and so on when determining how and when to
implement these recommendations.
 All patients should be screened for SARS-CoV-2 by means of a thorough history and physical examination, as
well as reverse transcription-polymerase chain reaction (RT-PCR) testing whenever possible, prior to under-
going elective surgery.
 Patients who are currently infected with coronavirus disease 2019 (COVID-19) should not undergo elective surgery.
 These guidelines are based on the available scientific evidence, albeit scant. The recommendations have been
reviewed and voted on by the expert delegates who produced this document.
As the coronavirus disease 2019 (COVID-19) pandemic begins
to loosen its initial grip on the globe andwe contemplate starting
the long road back toward normalcy, the medical community
will be facing many challenges, none more paramount than
preventing the further spread of COVID-19 and limiting the
possibility and the extent of a potential “second wave.”
The purpose of the present report is to provide a list of
recommendations aimed at reducing pathogen transfer during
the reintroduction of elective orthopaedic surgical procedures,
with a specific focus on preventing the spread of severe acute
respiratory syndrome (SARS)-CoV-2 infection. Although we
are assuming that we will be operating on patients without
SARS-CoV-2 infection, because of the complexities involved in
accurate diagnosis of SARS-CoV-2 infection, including up to
40% false-negative results for reverse transcription-polymerase
chain reaction (RT-PCR) tests1, we believe that precautions
need to be in place to minimize the chance of infection
transmission by potentially infected patients.
We realize that the situation is evolving on a daily basis
and that some of the recommendations in the present report
may need to be altered as new evidence emerges. In addition,
we are aware that the infection-prevention measures described
in the present report will highly depend on the prevalence of
COVID-19 in the affected areas and the ability to implement
*A list of the International Consensus Group (ICM) and Research Committee of the American Association of Hip and Knee Surgeons (AAHKS) members is
provided in a note at the end of the article.
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the recommended diagnostic tests to properly rule out
COVID-19 prior to surgery. We will continue to monitor the
literature and update this document as needed.
Methods
The present document is the result of work by 77 expert phy-
sicians in orthopaedic surgery, infectious disease, microbiology
and virology, and anesthesia. The members were selected on
the basis of their published or clinical expertise in infection
prevention, and all members live in countries affected by
COVID-19. The set of questions, recommendations, and
rationale were developed following the Delphi method. The
initial document was reviewed and voted on by all members.
The document was then revised, taking into account—but not
always incorporating—the comments of the delegates. The
revised document was then sent to the delegates for another
round of voting. In cases in which the comment made by a
delegate could not be comprehended or required clarification,
email or telephone contact with the delegate was established.
Once the final questions and rationales were developed, the
grade of each recommendationwas determined. This grade was
based on the strength of the supporting literature in addition to
the confidence of the participating members regarding the
recommendation. The final document, which included tabu-
lated votes, was shared by the delegates for 1 final review. Some
minor errors were detected during the third round of evalua-
tion and were corrected.
Limitations
As stated above, we understand that the situation with
COVID-19 is evolving on a daily basis. It is possible that some of
the recommendations may need to be changed or even reversed
as further evidence emerges. It is also plausible that surgeons,
infectious-disease physicians, nurses, and hospital administra-
tors may disagree with some of the recommendations. Fur-
thermore, each region and hospital system may have specific
limitations that may render some of these recommendations
impossible to implement. We have tried to construct these
guidelines to be as “universal” as possible while keeping these
unique characteristics in mind. These guidelines are not meant
to be strictly enforced but rather to serve as a resource for sur-
geons, staff, and administrators to use when constructing their
individual plans. Last, a psychometric analysis of the questions
was not conducted. This document and its Appendix will be
updated online as new data become available.
Please note that the rationale behind each recommen-
dation is provided in the Appendix along with additional
references.I
General
Question I.1: When Will the SARS-CoV-2 Pandemic End?
Response/Recommendation: Unknown. Epidemics/pan-
demics end when:
1. A large portion of the society has acquired immunity
with neutralizing antibodies to the pandemic agent
after being infected, leaving a small percentage of
individuals susceptible to infection (herd immunity)2.
This occurred with the Spanish Flu in 1918 caused by
influenza A (H1N1), when >60% of the population
was infected, and, to some extent, with the following
swine flu in 2009, which infected >60 million people
in the United States,
2. The pathogen (virus) mutates sufficiently to become
nonvirulent,
3. An effective treatment against the disease is available,
or
4. An effective vaccine against the virus is developed and
delivered to the population.
Grade of Recommendation: Moderate
Delegate vote: Agree (100%)
Question I.2: How Can Hospitals or Surgery Centers Know
When They Should Resume Elective Procedures?
Response/Recommendation: Elective surgery may be
resumed when2,3:
1. Lockdown in the region has been lifted and a
mandate allowing return to elective surgery has been
issued by local/state/provincial/governmental
authorities,
2. The number of COVID-19 cases in the region has been
consistently declining,
3. The hospital/surgical facility has the capacity to admit
non-COVID-19 patients to an area of the hospital
separated from COVID-19-positive patients,
4. The facility has an adequate supply of effective
personal protective equipment (PPE), has RT-PCR-
testing kits for SARS-CoV-2 virus, and is able to per-
form surgery safely with low risk of transmission of
SARS-CoV-2 virus,
5. The facility is able to maintain social distancing
throughout the process in all phases (preoperatively,
intraoperatively, and postoperatively), and
6. The facility has an adequate stockpile of necessary
equipment for a potential second wave.
Grade of Recommendation: Moderate
Delegate vote: Agree (97.5%), Disagree (2.5%)
Question I.3: Should Patients with Active COVID-19 Undergo
Elective Surgery?
Response/Recommendation: The Centers for Disease Con-
trol and Prevention (CDC) has guidelines based on testing and
non-testing that are useful for defining recovery4, including
14 days of quarantine and the absence of fever and other
symptoms. It is the opinion of this group that elective surgery
should be delayed in patients with active COVID-19 until they
are shown to have recovered from the infection as defined by
local guidelines5.
Grade of Recommendation: Weak
Delegate vote: Agree (100%)
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Question I.4: Should Elective Surgery Be Delayed in Elderly
Patients or Those with Comorbidities That Place Them at
High Risk for COVID-19?
Response/Recommendation: It is the opinion of this group
that elective surgery should be risk-stratified and possibly
deferred on the basis of patient age (‡75 years), morbid obesity,
diabetes, uncontrolled hypertension, chronic pulmonary dis-
ease, obstructive sleep apnea, chronic heart disease, and
immunocompromised state (e.g., because of organ or bone
marrow transplantation, active cancer, or current or recent
chemotherapy or radiation therapy) in the early days when
elective surgery is resumed6. Patients with substantial comor-
bidities and risk factors should be scheduled after healthier
patients have been treated and experience has been amassed
from the establishment of screening, prevention, and treatment
protocols.
Grade of Recommendation: Weak
Delegate vote: Agree (98.75%), Abstain (1.25%)
Question I.5: What Type of Education Should Patients
Receive Prior to Undergoing Elective Surgery During the
Pandemic Related to Risk of SARS-CoV-2 Transmission?
Response/Recommendation: It is critical for patients
undergoing elective surgery to be educated on the protocols
that are in place to minimize SARS-CoV-2 transmission to
themselves, family members, other patients, and hospital per-
sonnel. An overview of the protocols implemented by the
hospital to reduce the risk of transmission of the infection
should be included7 (see Appendix Fig. 1).
Grade of Recommendation: Strong
Delegate vote: Agree (100%)
Question I.6: Can Patients/Individuals Who Were Infected
with SARS-CoV-2 Be Infected with SARS-CoV-2 Again?
Response/Recommendation: Unclear. There have been
reports of individuals who have contracted COVID-19,
recovered, and then tested positive for SARS-CoV-2 again2.
Grade of Recommendation: Strong
Delegate vote: Agree (95%), Abstain (5%)II
Preoperative
Question II.1: What Additional Steps Should Be Taken
During the Pre-Admission Process for Patients Undergoing
Elective Surgery During the SARS-CoV-2 Pandemic?
Response/Recommendation: This workgroup recommends
that:
 Information on TOCC (travel, occupation, contact,
cluster) should be obtained and documented. Screen-
ing for symptoms (see Question II.3) of COVID-19
should be performed and documented.
 If the patient is given a RT-PCR test for SARS-CoV-2,
the test should be performed within 3 to 7 days before
elective surgery and the result should be documented
in the clinical charts of the patient. Appropriate clinical
and/or microbiological screening procedures for each
patient should be undertaken.
 Additional education should be provided to the patient
regarding infection-prevention protocols (hand
hygiene, wearing a mask, etc.).
 All patients and providers should use a surgical mask
during encounters. Providers should use protective
eyewear as well7,8.
 The risk of infection and transmission should be
minimized by utilizing general social distancing
principles.
 “No eating or drinking” rules in restricted areas need
to be enforced.
 Patients should avoid the use of common spaces or
surfaces (e.g., check-in desks), when possible, and
these surfaces should be thoroughly cleaned between
patients. Bedside check-in should be encouraged.
 The use of waiting rooms should be minimized. Social
distancing in the waiting room and other communal
areas should be exercised. Frequent cleaning is also
recommended.
 Family members and visitors should limit the time that
they spend within the hospital. Some institutions may
ban the entry of family members and visitors to the
hospital.
 The surgeon and the surgical team should avoid direct
contact with family members and should update the
families via telephone or video conferencing.
 Family members of pediatric patients should be
screened for SARS-CoV-2 before pediatric surgery.
 Patients should be housed in single rooms, if possible.
When patients are housed in the same room, the beds
should be distanced at least 2 m (6 ft) from each other,
and all patients should wear a surgical mask.
 Commonly touched surfaces should be wiped down
and cleaned with an effective disinfectant solution
(e.g., 70% alcohol) at least twice a day.
 Any close contact with the patient should be done with
use of appropriate PPE, as directed by the institutional
policy and in conjunction with national and local
guidelines.
 In the early weeks following the return to elective
surgery, each patient should be placed in a single room
or cubicle where check-in, registration, and other
administrative tasks can be performed.
 Consideration should be given to having a screening
ward to house patients, especially those who may not
have been tested for SARS-CoV-2 preoperatively.
 Large surgical bays with multiple patients sharing
1 room should be avoided.
 Consideration should be given to the use of portable
high-efficiency particulate air (HEPA) filtration sys-
tems in relatively crowded areas/rooms.
 Presently, in most parts of China, even low-prevalence
areas, the patients are required to have a green digital
health code and 1 negative RT-PCR test prior to
undergoing their planned procedure. This code sig-
nifies that the patient has not been infected with
3
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COVID-19 and can undergo procedures and partake
in daily activities with general precautions. In the
absence of the green code, patients are quarantined for
2 weeks.
Grade of Recommendation: Moderate
Delegate vote: Agree (97.5%), Abstain (2.5%)
Question II.2: Should Asymptomatic Patients Undergoing
Elective Surgery Wear Protective Masks During the SARS-CoV-2
Pandemic?
Response/Recommendation: It is the opinion of this group
that all patients entering a hospital to undergo elective surgery
should wear a mask9-12.
Grade of Recommendation: Weak
Delegate vote: Agree (97.5%), Disagree (1.25%), Abstain
(1.25%)
Question II.3: Should Patients Undergoing Elective Surgery Be
Screened for Symptoms of COVID-19 During the Pandemic?
Response/Recommendation: Yes. All patients undergoing
surgery during the pandemic should have their temperature
and pulse oximetry measured and be screened with a series of
questions that will stratify them into various risk groups4. The
questions should aim to ask the patients about COVID-19
symptoms (fever, shortness of breathing, cough, loss of smell
and taste, diarrhea, headache, sore throat) (see Appendix Table
I)13 as well as TOCC information (travel to regions with a high
prevalence of COVID-19, occupation with a high risk of
COVID-19 infection, contact with people known to be infected
with COVID-19, or close proximity with a COVID-19-positive
case). Those with a high risk of being infected should have
surgery deferred, and should be quarantined as per local
guidelines, unless adequate testing can be performed to rule out
COVID-19.
Grade of Recommendation: Moderate
Delegate vote: Agree (98.75%), Disagree (1.25%)
Question II.4: Should Patients Undergoing Elective Surgery
Be Tested for SARS-CoV-2? If So, Should the Testing Be Done
on All Patients or a Select Group?
Response/Recommendation: RT-PCR testing for SARS-
CoV-2 is becoming more accessible. Testing of patients
should be mandatory in high-prevalence areas given the risk of
disease transmission by asymptomatic patients14,15. Routine
testing is not feasible in all locations because of limitations in
testing capacity, and therefore local guidelines should be fol-
lowed in these areas.
Grade of Recommendation: Strong
Delegate vote: Agree (96.25%), Disagree (1.25%),
Abstain (2.5%)
Question II.5: For Patients Being Considered for Molecular
Testing of SARS-CoV-2, What Type of Test Should Be Used?
Response/Recommendation: We recommend an RT-PCR test
for SARS-CoV-2 that is known to have high sensitivity and
negative predictive value4,15,16. Currently, a nasopharyngeal swab
appears to have a reasonable yield, although an RT-PCR of a
combination of saliva, sputum, or the use of oropharyngeal swab
is also effective. These alternative tests may replace the more
painful and invasive nasopharyngeal tests in the future. Next-
generation sequencing (NGS), CRISPR/Cas-9, and other
molecular techniques can be used as an adjunct when available.
Emerging data suggest that specimens should be transported in
media (virus transport medium, universal transport medium, or
saline solution) approved for use with each respective testing
platform.
Grade of Recommendation: Strong
Delegate vote: Agree (100%)
Question II.6: Should Antibody Testing for SARS-CoV-2 Be
Performed? If So, in Whom Should This Test Be Carried Out?
Response/Recommendation: At this time, we are aware of no
data to support routine antibody testing of patients undergoing
elective surgery. There are a number of serum antibody tests
available, including point-of-care (POC) lateral flow tests. The
accuracy of these kits in detecting the relevant antibody against
SARS-CoV-2 is variable. There is also genetic variability in
SARS-CoV-2 strains being isolated in different parts of the
world, which may limit the accuracy of current antibody tests.
The degree of immunity conferred with detectable antibodies
and the importance of antibody quantification are unknown at
this time2.
Grade of Recommendation: Strong
Delegate vote: Agree (96.25%), Disagree (1.25%),
Abstain (2.5%)
Question II.7: What Additional Tests Other Than Molecular
and Serology Tests Are Available to Detect SARS-CoV-2 and
When Should They Be Done?
Response/Recommendation: For patients with symptoms
suggestive of COVID-19 but a negative SARS-CoV-2 RT-PCR
test, repeat testing should be considered. If the result is still
negative, and without any alternative explanation for the
patient’ symptoms, a chest radiograph and a low-dose com-
puted tomographic (CT) scan of the chest should be performed
to determine if COVID-19-specific lung abnormalities are
present17. Elective surgery should be deferred in this patient
population.
Grade of Recommendation: Strong
Delegate vote: Agree (95%), Disagree (3.75%), Abstain
(1.25%)III
Intraoperative
Question III.1: What Considerations Should Be Given to the
Operating Room Ventilation Systems While SARS-CoV-2 Is
Still Highly Prevalent and Elective Cases Are Resumed?
Response/Recommendation: The operating room ventila-
tion system should reduce the presence of airborne pathogens
to a minimum18-20. We recommend to:
1. Have a ventilation system in the operating roomwith a
minimum of 20 air changes per hour.
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2. Reduce the amount of equipment in the operating
room and limit it to what is essential for the surgical
procedure.
3. Install filters that are able to remove aerosol and
droplets, such as HEPA filters.
4. Have normal positive-pressure rooms for elective
procedures. There is no need to convert to negative-
pressure rooms, but modalities to decrease efflux of
contaminated air into the hallways, such as in-room
air filters and negative-pressure antechambers, can be
considered.
5. Minimize the number of people in the operating room
at all times, particularly during intubation or extuba-
tion of a patient.
Grade of Recommendation: Strong
Delegate vote: Agree (98.75%), Abstain (1.25%)
Question III.2: Should Standard Surgical Helmets and
Protection Suits Be Utilized When Performing Elective
Surgery During the SARS-CoV-2 Pandemic?
Response/Recommendation: We recommend that surgical
helmets should not be used as the primary protection against
aerosol and airborne diseases, including COVID-19. Fans
within the helmets and the helmets themselves can harbor
viruses, and these devices cannot be sterilized between proce-
dures, increasing the potential spread of infection from patients
to surgeons or from surgeons to the next patient. If, however,
surgical helmet use is mandated by the hospital standard
protocols for total joint arthroplasty, this should be continued
with appropriate disinfection protocols in place, and an N95
(or equivalent) mask should also be worn when using the
helmet.
Grade of Recommendation: Strong
Delegate vote: Agree (93.75%), Disagree (1.25%),
Abstain (5%)
Question III.3: What Type of Protective Equipment Should
Surgeons and Assistants Utilize During Elective Surgery
Performed at the Time of the SARS-CoV-2 Pandemic?
Response/Recommendation: In areas of high prevalence of
COVID-19, and during surgery on patients who have not been
RT-PCR-tested for SARS-CoV-2, we recommend that surgeons
and the entire surgical team who scrub during the case wear a
mask (preferably N95, filtering face piece (FFP)2, or P3)21
and a face shield with a neck cover that wraps around the face
and has an extension that can be placed inside the gown. In the
absence of a face shield, protective eyewear that provides a seal
around the eyes (i.e., goggles) should be worn. In patients who
have been tested for SARS-CoV-2 by RT-PCR within 3 days
before surgery and quarantined for 14 days prior to elective
surgery, regular protective equipment (surgical mask, etc.) may
be worn. These measures should be implemented until the
pandemic ends. Global variation in access to the aforemen-
tioned PPE will influence the implementation of some of these
guidelines.
Grade of Recommendation: Strong
Delegate vote: Agree (98.75%), Disagree (1.25%)
Question III.4: Does the Type of Anesthesia Influence the
Potential Spread of COVID-19?
Response/Recommendation: Yes. General anesthesia that
requires airway manipulation, endotracheal intubation, and
positive ventilation is more likely to predispose the anesthesia
and surgical team to transmission of SARS-CoV-222. The use of
regional anesthesia, whenever possible, should be strongly
considered for patients undergoing elective surgery during the
pandemic.
Grade of Recommendation: Moderate
Delegate vote: Agree (97.5%), Disagree (1.25%), Abstain
(1.25%)
Question III.5: What Precautions Should Be Taken by the
Operative Staff During Elective Surgery Performed at the
Time of the SARS-CoV-2 Pandemic?
Response/Recommendation: A number of precautions
should be taken by the operative staff, including21:
1. Limiting the number of people in the operating room,
2. Reducing door opening in the operating room,
3. Cautious use of electrocautery and judicious use of
suction to remove smoke,
4. Keeping the power setting to as low as possible when
high-power tools are being used, or considering
using a Gigli saw, sharp osteotomes, and manual
reaming whenever possible, and
5. Keeping equipment in the room to a minimum. This
includes navigation consoles, x-ray machines, and
robots, all of which represent surfaces for contami-
nation by the virus.
Grade of Recommendation: Strong
Delegate vote: Agree (97.5%), Disagree (1.25%), Abstain
(1.25%)
Question III.6: Should Additional Cleaning or Sterilization of
Instruments Be Performed for Elective Surgical Procedures
During the SARS-CoV-2 Pandemic?
Response/Recommendation: The standard recommenda-
tions for cleaning and sterilizing of instruments are still ade-
quate and need to be followed vigilantly. We refer to the
standards posited by the Association for the Advancement of
Medical Instrumentation (AAMI) and the Association of per-
iOperative Registered Nurses (AORN)23,24.
Grade of Recommendation: Moderate
Delegate vote: Agree (98.75%), Abstain (1.25%)
Question III.7: How Should Each Operating Room Be
Cleaned in Between Cases During the SARS-CoV-2
Pandemic?
Response/Recommendation: Consideration should be given
to performing a thorough cleaning of the room at the end of
5
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each case. The surfaces of all equipment in the operating room
(including computers, lead gowns, robots, case carts, and so
on) should be wiped down after each case. Manufacturer’s
instructions on the surface contact time requirements of the
disinfectant, which can range from 4 to >10 minutes, must be
followed25.
Grade of Recommendation: Strong
Delegate vote: Agree (93.75%), Abstain (6.25%)
Question III.8: How Should the Surgeon and the Surgical
Team Clean Themselves Following the Conclusion of Each
Procedure During the SARS-CoV-2 Pandemic?
Response/Recommendation: The surgeon and the surgi-
cal team should change scrubs frequently during a surgical
day. If respirators (N95, FFP2, P3) are being worn, they
can be used for 6 to 8 hours and need not be discarded
after each use unless soiled. A new respirator is required
each day.
Grade of Recommendation: Strong
Delegate vote: Agree (97.5%), Disagree (1.25%), Abstain
(1.25%)
Question III.9: Are There Any Considerations to Give
Toward, or Concerns Regarding, Surgeons Utilizing Multiple
Operating Rooms During the Operative Day?
Response/Recommendation: Because of the im-
plementation of extra steps aimed at reducing the trans-
mission of COVID-19 and an expected decline in operating
room efficiency, the use of multiple operating rooms is
preferred, whenever possible26. This would allow one of the
surgeon’s rooms to be cleaned while another room is being
used for surgery. However, the surgeon and surgical team
should strictly follow the personal cleansing procedures
between cases.
Grade of Recommendation: Strong
Delegate vote: Agree (97.5%), Abstain (2.5%)
Question III.10: Should Wound Closure Be Altered in
Patients Undergoing Elective Surgery?
Response/Recommendation: The use of suture material
(such as staples and nonabsorbable sutures) that requires the
patient to return to the office, or a visit by a nurse, for suture
removal should be minimized8. The wound should also be
covered in an occlusive dressing.
Grade of Recommendation: Strong
Delegate vote: Agree (96.25%), Disagree (1.25%),
Abstain (2.5%)IV
Postoperative
Question IV.1: What Steps Should Be Taken if a Patient Who
Underwent Elective Surgery Tests Positive for SARS-CoV-2 in
the Postoperative Period?
Response/Recommendation: If a patient is positive for
SARS-CoV-2 on RT-PCR testing after a surgical procedure,
all health-care workers who came into contact with the
patient without using PPE and are not known to have anti-
bodies against SARS-CoV-2 should be tested and quaran-
tined until the test results become available12. Decisions
regarding the need to quarantine staff should be made in
tandem with the hospital infection-control team and
employee health department. The patient also should be
isolated, and any contact with the patient should occur with
use of full PPE.
Grade of Recommendation: Strong
Delegate vote: Agree (96.25%), Disagree (2.5%), Abstain
(1.25%)
Question IV.2: What Changes Should Be Implemented in
the Recovery Room and in the Postoperative Care of
Patients?
Response/Recommendation: In the post-anesthesia care unit
(PACU):
1. Patients should be separated from each other by a
minimum distance of 2 m (6 ft).
2. Personnel taking care of the patient should be wearing
an appropriate mask at all times.
3. Patient stay in the recovery area should be minimized
while maintaining perioperative safety.
4. Overcrowding and nonessential personnel traffic
should be avoided.
5. Patients who could not be extubated in the operating
room should be transferred to the intensive care unit
(ICU) directly, bypassing the PACU.
6. Surfaces around the bed of each patient in the PACU
should be wiped down after transfer of the patient and
prior to arrival of the next patient26.
7. Consideration should be given to recovering patients
in the operating room and bypassing the PACU, if
possible27.
8. Consideration should be given to the use of a
separate PACU or recovery space for non-COVID-
19 cases and short-stay cases, to avoid admission to
hospital floors where exposure to SARS-CoV-2 may
be higher.
Grade of Recommendation: Moderate
Delegate vote: Agree (100%)
Question IV.3: Should Patients Wear a Mask in the
Postoperative Period During the SARS-CoV-2 Pandemic? If
So, What Type?
Response/Recommendation: All patients should wear
a surgical mask postoperatively12. This will decrease the
spread of droplets during coughing, sneezing, and
talking while patients are mildly incapacitated and may not
be able to control these functions as they would without
anesthesia.
Grade of Recommendation: Moderate
Delegate vote: Agree (97.5%), Disagree (1.25%), Abstain
(1.25%)
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Question IV.4: Should Routinely Performed
Postoperative Radiographs Be Made in the PACU or
Somewhere Else?
Response/Recommendation: It is preferable for postopera-
tive radiographs to be made in the operating room. If radio-
graphs need to be made in the PACU, the x-ray plate and other
equipment coming into contact with the patient should be
thoroughly cleaned after use.
Grade of Recommendation: Weak
Delegate vote: Agree (93.75%), Disagree (2.5%), Abstain
(3.75%)
Question IV.5: Should the Antibiotic or Venous
Thromboembolism (VTE) Prophylaxis Be Altered in Patients
Undergoing Elective Surgery During the SARS-CoV-2
Pandemic?
Response/Recommendation: No. The available data on
thrombotic risk in COVID-19 patients is limited, although an
increased risk of thromboembolic disease has been reported28.
VTE prophylaxis needs to be administered to patients with
COVID-19, unless there is a contraindication (bleeding risk
and so on). The type of VTE prophylaxis for patients under-
going elective surgery needs to be determined by the treating
surgeon and does not need to differ from the protocols used
prior to the pandemic. Bacterial coinfection in patients with
COVID-19 is low, and there is no need to alter the antibiotic
prophylaxis.
Grade of Recommendation: Strong
Delegate vote: Agree (98.75%), Abstain (1.25%)
Question IV.6: Should Any Changes Be Made in
Postoperative Care Protocols for Patients Undergoing Elective
Surgery During the SARS-CoV-2 Pandemic?
Response/Recommendation: This workgroup recommends
that the following changes be made in the postoperative care of
patients during the pandemic:
1. The length of hospital stay for patients should be
minimized.
2. Postoperative rounds by the surgeon may be done with
use of telemedicine, whenever possible.
3. Patients should be discharged home, and transfer to
inpatient rehabilitation should be minimized.
4. The patient should be instructed how to perform self-
directed physical therapy at home.
5. Post-discharge visits to the office should beminimized,
with the majority of the follow-up being done by
telemedicine.
6. Office visits should be limited to those who are
having issues/complications such as wound-
healing problems, suspected fracture, stiffness, and
so on.
7. Digital health programs and wearable sensor
technologies that allow monitoring of patients will
play a larger role in management of patients in the
future.
8. Social distancing should be resumed and at-home
visits avoided, unless absolutely essential.
Grade of Recommendation: Moderate
Delegate vote: Agree (100%)
Question IV.7: What Considerations, if Any, Should Be Given
to the Use of Nonsteroidal Anti-Inflammatory Drugs
(NSAIDS) for Patients Undergoing Elective Surgery During
the SARS-CoV-2 Pandemic?
Response/Recommendation: This workgroup recommends
that nonsteroidal anti-inflammatory drugs (NSAIDs) can be
used, as part of a multimodal analgesia regimen, in patients
who do not have COVID-19 infection and have undergone
elective surgery.
Grade of Recommendation: Moderate
Delegate vote: Agree (97.5%), Disagree (1.25%), Abstain
(1.25%)
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